Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Betaine is a major osmolyte, also important in methyl group metabolism. Concentrations of betaine, its metabolite dimethylglycine and analog trimethylamine-N-oxide (TMAO) in blood are cardiovascular risk markers. Diabetes disturbs betaine: does diabetes alter associations between betaine-related measures and cardiovascular risk? METHODS: Plasma samples were collected from 475 subjects four months after discharge following an acute coronary admission. Death (n = 81), secondary acute MI (n = 87), admission for heart failure (n = 85), unstable angina (n = 72) and all cardiovascular events (n = 283) were recorded (median follow-up: 1804 days). RESULTS: High and low metabolite concentrations were defined as top or bottom quintile of the total cohort. In subjects with diabetes (n = 79), high plasma betaine was associated with increased frequencies of events; significantly for heart failure, hazard ratio 3.1 (1.2-8.2) and all cardiovascular events, HR 2.8 (1.4-5.5). In subjects without diabetes (n = 396), low plasma betaine was associated with events; significantly for secondary myocardial infarction, HR 2.1 (1.2-3.6), unstable angina, HR 2.3 (1.3-4.0), and all cardiovascular events, HR 1.4 (1.0-1.9). In diabetes, high TMAO was a marker of all outcomes, HR 2.7 (1.1-7.1) for death, 4.0 (1.6-9.8) for myocardial infarction, 4.6 (2.0-10.7) for heart failure, 9.1 (2.8-29.7) for unstable angina and 2.0 (1.1-3.6) for all cardiovascular events. In subjects without diabetes TMAO was only significant for death, HR 2.7 (1.6-4.8) and heart failure, HR 1.9 (1.1-3.4). Adding the estimated glomerular filtration rate to Cox regression models tended to increase the apparent risks associated with low betaine. CONCLUSIONS: Elevated plasma betaine concentration is a marker of cardiovascular risk in diabetes; conversely low plasma betaine concentrations indicate increased risk in the absence of diabetes. We speculate that the difference reflects control of osmolyte retention in tissues. Elevated plasma TMAO is a strong risk marker in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, elevated plasma TMAO levels have been found in people at risk of CVD. These patients usually show greater concentrations of the TMAO precursors too.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this context, it is thought that TMAO could serve as a biomarker in humans to predict prevalence of CVD and increased incidence of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke and even death [7,14,52,53,54,55].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Numerous recent case–control and longitudinal studies have shown a striking association between trimethylamine N‐oxide (TMAO) levels and cardiovascular disease risks in a variety of cohorts.1, 2, 3, 4, 5, 6, 7, 8, 9, 10”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In humans, recent clinical studies evidence a positive correlation between elevated plasma levels of TMAO and an increased risk for major adverse cardiovascular events.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“we also performed a sensitivity analysis for the 18 data when we replaced RRs for all‐cause mortality in these publications7, 10, 22, 26; the pooled RR was 1.69 (95% CI, 1.52, 1.89; P<0.001; P heterogeneity=0.6; I2=0%).”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 7×
“These are not only the TMAO that is found in many fish [38], but also other substituted trimethylamines such as choline [23, 24] and carnitine [40].”
BackgroundResultInfluentialIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442 · cited 1×
“Although supplementation with folate, vitamin B12 and vitamin B6 is effective in lowering plasma homocysteine levels, these supplements have not been observed to have any effect on the risk of secondary coronary events [15–17].”
BackgroundCraig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559 · cited 8×
“These are not only the TMAO that is found in many fish [38], but also other substituted trimethylamines such as choline [23, 24] and carnitine [40].”
BackgroundResultInfluentialAlbert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism
Lever, M., & Slow, S. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.009 · Cited by 460
Self-citation
Research works printed but not linked: 1
- Ratnam S, Wijekoon EP, Hall B, Garrow TA, Brosnan ME, et al (2006) Am J Physiol Endocrinol Metab. 290: E933– E939. 16352668
Cited by
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“…of TMAO have been shown in multiple distinct clinical studies and cohorts to be associated with CVD risks (Wang et al., 2011; Tang et al., 2013; Lever et al., 2014; Wang et al., 2014a; Tang et al., 2015 ; Trøseid et al., 2015), and targetted suppression of microbial TMA/TMAO production has…”
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
“…TMAO levels are associated with risks for both prevalent atherosclerotic heart disease and incident major adverse cardiac events in multiple independent cohorts (Koeth et al., 2013; Lever et al., 2014; Mente et al., 2015; Tang et al., 2013, 2014; Trøseid et al., 2015; Wang et al., 2011, 2014b).”
BackgroundGut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Seldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
“, (2014) [53] found that high levels of betaine were associated with cardiovascular risk (CVR) only in diabetic patients.”
BackgroundSchiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563
“Interestingly, all-cause mortality reported from other continents, based on results from a single study enrolling 475 patients in New Zealand, was also statistically associated with TMAO levels.(22)”
BackgroundHeianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
“In diabetic patients, increased plasma TMAO concentrations were associated with death, myocardial infarction, heart failure, unstable angina, and other cardiovascular events (69).”
BackgroundMicrobial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Chen, S., Henderson, A., Petriello, M. C., Romano, K. A., Gearing, M., Miao, J., Schell, M., Sandoval-Espinola, W. J., Tao, J., Sha, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.021 · Cited by 427
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 400
Thirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., Polhemus, D. J., Tang, W. H. W., Wu, Y., Hazen, S. L., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002314 · Cited by 382
“4) subjects alike.(14) In further studies, elevated TMAO levels were observed among subjects (n=112) with extensive serial echocardiography, and similarly were associated with more advanced left ventricular (LV) diastolic dysfunction and predicted poorer long-term adverse clinical outcomes independent of cardiac and r…”
BackgroundResultGlycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
Alves, A., Bassot, A., Bulteau, A.-L., Pirola, L., & Morio, B. (2019) · Nutrients · doi:10.3390/nu11061356 · Cited by 365
“, betaine (trimetylglycine) [82,83] and dimethylglycine [84].”
Chen, Y.-M., Liu, Y., Zhou, R.-F., Chen, X.-L., Wang, C., Tan, X.-Y., Wang, L.-J., Zheng, R.-D., Zhang, H.-W., Ling, W.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep19076 · Cited by 358
TMAO: A small molecule of great expectations
Ufnal, M., Zadlo, A., & Ostaszewski, R. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.006 · Cited by 319
Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway
Geng, J., Yang, C., Wang, B., Zhang, X., Hu, T., Gu, Y., & Li, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.016 · Cited by 297
Schugar, R. C., Shih, D. M., Warrier, M., Helsley, R. N., Burrows, A., Ferguson, D., Brown, A. L., Gromovsky, A. D., Heine, M., Chatterjee, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.077 · Cited by 291
“In agreement with our findings here, several independent groups have found an association between circulating TMAO levels and both T2DM and the heightened adverse CVD outcomes in diabetics (Lever et al., 2014; Dambrova et al., 2016; Tang et al., 2017).”
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
Qi, J., You, T., Li, J., Pan, T., Xiang, L., Han, Y., & Zhu, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13307 · Cited by 268
“Of them, five later studies, which enroled patients with heart failure (HF), chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), PAD and stable CAD, were extended subgroup follow-ups from the first large cohort with overlaps in studying population and were thus not considered for pooling outcome in our meta…”
BackgroundInfluentialIntersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
“This has been replicated in other cohorts, whereby higher TMAO levels portend increased risk of HF hospitalization [61].”
ResultTang, W. H. W., Wang, Z., Li, X. S., Fan, Y., Li, D. S., Wu, Y., & Hazen, S. L. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.263640 · Cited by 231
“Previous studies have suggested that patients with T2DM may have increased TMAO concentrations compared to patients without T2DM (17); however whether or not this relationship was confounded by glycemic control or renal function is unclear.”
BackgroundDiabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels
Dambrova, M., Latkovskis, G., Kuka, J., Strele, I., Konrade, I., Grinberga, S., Hartmane, D., Pugovics, O., Erglis, A., & Liepinsh, E. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1569330 · Cited by 229
“Also in diabetic patients, high TMAO was found to be a strong marker of all cardiovascular events [3].”
Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 218
“Among those with T2DM, high TMAO was associated with excess risk for several cardiovascular events, including death, myocardial infarction, heart failure, and unstable angina; whereas, in subjects without diabetes, TMAO was associated only with death and heart failure [42].”
BackgroundMueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.091 · Cited by 217
Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-Díaz, J., Aragón-Vela, J., Muñoz-Quezada, S., Tercedor-Sánchez, L., & Abadia-Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 214
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
Shan, Z., Sun, T., Huang, H., Chen, S., Chen, L., Luo, C., Yang, W., Yang, X., Yao, P., Cheng, J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157107 · Cited by 210
Rohrmann, S., Linseisen, J., Allenspach, M., von Eckardstein, A., & Müller, D. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.220103 · Cited by 197
Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review
Zhang, D., Liu, J., Cheng, H., Wang, H., Tan, Y., Feng, W., & Peng, C. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111653 · Cited by 190
Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
Zhu, Y., Li, Q., & Jiang, H. (2020) · APMIS · doi:10.1111/apm.13038 · Cited by 196
Zhuang, R., Ge, X., Han, L., Yu, P., Gong, X., Meng, Q., Zhang, Y., Fan, H., Zheng, L., Liu, Z., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12843 · Cited by 179
“Notably, a recent study concluded that elevated plasma TMAO and betaine concentrations may be used as markers of cardiovascular risk in diabetic patients.(29) Further evidence demonstrated that TMAO levels were significantly higher in people with diabetes than in nondiabetic individuals.”
BackgroundLi, D., Lu, Y., Yuan, S., Cai, X., He, Y., Chen, J., Wu, Q., He, D., Fang, A., Bo, Y., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac074 · Cited by 178
Trimethylamine N‐oxide: breathe new life
Subramaniam, S., & Fletcher, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13959 · Cited by 171
“Lever et al., 2014; Tang et al., 2016 Human -Plasma TMAO level is highly variable in the plasma and urine of overweight individuals with type 2 diabetes.”
BackgroundInfluentialMeyer, K. A., Benton, T. Z., Bennett, B. J., Jacobs, D. R., Lloyd‐Jones, D. M., Gross, M. D., Carr, J. J., Gordon‐Larsen, P., & Zeisel, S. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003970 · Cited by 172
Fu, B. C., Hullar, M. A., Randolph, T. W., Franke, A. A., Monroe, K. R., Cheng, I., Wilkens, L. R., Shepherd, J. A., Madeleine, M. M., Le Marchand, L., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa015 · Cited by 172
Microbiome, trimethylamine N-oxide, and cardiometabolic disease
Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Zhang, W., Miikeda, A., Zuckerman, J. E., Jia, X., Charugundla, S., Zhou, Z., Kaczor‐Urbanowicz, K. E., Magyar, C. E., Guo, F., Wang, Z., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80063-0 · Cited by 158
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 146
“Lever 2014 [80] 79 Coronary Disease Cohort Study (CDCS), participants with T2D 74.”
BackgroundUnravelling the involvement of gut microbiota in type 2 diabetes mellitus
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Sobarzo‐Sánchez, E., & BUNGAU, S. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119311 · Cited by 158
Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
Makrecka‐Kuka, M., Volska, K., Antone, U., Vilšķe̅rsts, R., Grīnberga, S., Bandere, D., Liepinsh, E., & Dambrova, M. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.017 · Cited by 150
Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński, A., & Ufnal, M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.001 · Cited by 139
Ferguson, J. F., Allayee, H., Gerszten, R. E., Ideraabdullah, F., Kris-Etherton, P. M., Ordovás, J. M., Rimm, E. B., Wang, T. J., & Bennett, B. J. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/hcg.0000000000000030 · Cited by 123
Yang, W., Zhang, S., Zhu, J., Jiang, H., Jia, D., Ou, T., Qi, Z., Zou, Y., Qian, J., Sun, A., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.004 · Cited by 124
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
Du, L., Li, Q., Yi, H., Kuang, T., Tang, Y. P., & Fan, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112839 · Cited by 131
Dumas, M.-E., Rothwell, A. R., Hoyles, L., Aranias, T., Chilloux, J., Calderari, S., Noll, E. M., Péan, N., Boulangé, C. L., Blancher, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.039 · Cited by 114
“, 2011b), the roles played by TMAO in glucose homeostasis are less clear (Bai et al., 1998; Gao et al., 2014; Lever et al., 2014; McEntyre et al., 2015).”
BackgroundWinther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H.-H., Hansen, T. W., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0048 · Cited by 112
“that these associations could be explained by confounding factors, including eGFR(30,31).”
BackgroundTrimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes
León‐Mimila, P., Villamil‐Ramírez, H., Li, X. S., Shih, D. M., Hui, S. T. Y., Ocampo‐Medina, E., López-Contreras, B. E., Morán‐Ramos, S., Olivares-Arévalo, M., Grandini-Rosales, P., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.07.010 · Cited by 119
“Moreover, several independent studies have reported associations between circulating TMAO levels and heightened adverse cardiovascular disease (CVD) outcomes in diabetic patients [16, 18, 19].”
BackgroundBrown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
“In addition to kidney disease, TMAO has also been linked to insulin resistance and type 2 diabetes mellitus (T2DM) by several independent groups (87, 88).”
BackgroundAnnunziata, G., Maisto, M., Schisano, C., Ciampaglia, R., Narciso, V., Tenore, G. C., & Novellino, E. (2019) · Nutrients · doi:10.3390/nu11010139 · Cited by 114
Mafune, A., Iwamoto, T., Tsutsumi, Y., Nakashima, A., Yamamoto, I., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1207-y · Cited by 103
“betes than in those without diabetes, which is also consistent with a recent article [17].”
ResultHuman Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics
Niedzwiecki, M. M., Samant, P., Walker, D. I., Tran, V., Jones, D. P., Prausnitz, M. R., & Miller, G. W. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04073 · Cited by 99
3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice
Wang, G., Kong, B., Shuai, W., Fu, H., Jiang, X., & Huang, H. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108341 · Cited by 100
Trimethylamine N-oxide impairs β-cell function and glucose tolerance
Kong, L., Zhao, Q., Jiang, X., Hu, J., Jiang, Q., Li, S., Peng, X., Wang, S., Chen, Y., Wan, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46829-0 · Cited by 110
“Diabetes in mice and humans is associated with increasing TMAO levels, as we and others have shown 14,15 (Fig.”
Pathogenic functions of host microbiota
Rath, S., Rud, T., Karch, A., Pieper, D. H., & Vital, M. (2018) · Microbiome · doi:10.1186/s40168-018-0542-0 · Cited by 106
“Those findings are consistent with analytical measurements that revealed increased TMAO levels in such patients [33], yet its role in the development of disease is not clear.”
ResultFrom role of gut microbiota to microbial-based therapies in type 2-diabetes
Ebrahimzadeh Leylabadlo, H., Sanaie, S., Sadeghpour Heravi, F., Ahmadian, Z., & Ghotaslou, R. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104268 · Cited by 92
Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study
Liu, J., Semiz, S., van der Lee, S. J., van der Spek, A., Verhoeven, A., van Klinken, J. B., Sijbrands, E., Harms, A. C., Hankemeier, T., van Dijk, K. W., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1239-2 · Cited by 92
Aldana-Hernández, P., Leonard, K.-A., Zhao, Y.-Y., Curtis, J. M., Field, C. J., & Jacobs, R. L. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz214 · Cited by 91
Prospective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2 Diabetes
Svingen, G. F. T., Schartum-Hansen, H., Pedersen, E. R., Ueland, P. M., Tell, G. S., Mellgren, G., Njølstad, P. R., Seifert, R., Strand, E., Karlsson, T., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.250761 · Cited by 90
Yao, M., Liao, P., Zhao, X., & Wang, L. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01310-5 · Cited by 96
Gut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 104
Lakshmi, G. B. V. S., Yadav, A. K., Mehlawat, N., Jalandra, R., Solanki, P. R., & Kumar, A. (2021) · Scientific Reports · doi:10.1038/s41598-020-80122-6 · Cited by 89
Zeng, Y., Guo, M., Xia, F., Teng, F., Tan, X., Li, X., Wang, M., Long, Y., & Xu, Y. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab010 · Cited by 103
“(62) were each included as 2 independent studies.”
BackgroundInfluentialTrimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction
Schuett, K. A., Kleber, M. E., Scharnagl, H., Lorkowski, S., März, W., Niessner, A., Marx, N., & Meinitzer, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.064 · Cited by 92
“Trimethylamine-N-oxide (TMAO), a microbiotaassociated metabolite, is associated with cardiovascular (CV) events in various populations (1), including patients with chronic heart failure (HF) (2,3).”
BackgroundNguyen, T. T., Kosciolek, T., Daly, R. E., Vázquez-Baeza, Y., Swafford, A., Knight, R., & Jeste, D. V. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.003 · Cited by 83
Zhou, Y., Zhang, Y., Jin, S., Lv, J., Li, M., & Feng, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117031 · Cited by 103
Trøseid, M., Hov, J. R., Nestvold, T. K., Thoresen, H., Berge, R. K., Svardal, A., & Lappegård, K. T. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0120 · Cited by 84
Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality
Kanitsoraphan, C., Rattanawong, P., Charoensri, S., & Senthong, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0252-z · Cited by 91
Farràs, M., Martínez-Gili, L., Portune, K. J., Arranz, S., Frost, G. S., Tondo, M., & Blanco‐Vaca, F. (2020) · Nutrients · doi:10.3390/nu12082200 · Cited by 93
He, X., Ji, G., Jia, W. P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030300 · Cited by 89
“betaine Regulates the LXRα/PPARα pathway and alleviates ER stress; predictor of cardiovascular outcomes NAFLD, diabetes [114,115]”
BackgroundYu, D., Shu, X., Rivera, E. S., Zhang, X., Cai, Q., Calcutt, M. W., Xiang, Y., Li, H., Gao, Y., Wang, T. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010606 · Cited by 85
“This is in line with results from some prior studies showing stronger associations of these metabolites with MACE among diabetic participants than nondiabetic participants.(5,8) As discussed earlier, diabetes mellitus and antidiabetic medications can alter the gut microbiota, anddiabetesmellitus is an establishedCVD r…”
ResultLuo, Q., Hu, Y., Chen, X., Luo, Y. K., Chen, J., & Wang, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.899746 · Cited by 98
“where plasma betaine concentrations were independently associated with incidence of heart failure (33, 34).”
BackgroundOktaviono, Y. H., Lamara, A. D., Saputra, P. B. T., Arnindita, J. N., Pasahari, D., Saputra, M. E., & Suasti, N. M. A. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.8893 · Cited by 98
Gao, J., Yan, K.-T., Wang, J.-X., Dou, J., Wang, J., Ren, M., Ma, J., Zhang, X., & Liu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-59235-5 · Cited by 80
Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus
Li, P., Zhong, C., Li, S., Sun, T., Huang, H., Chen, X., Zhu, Y., Hu, X., Peng, X., Zhang, X., et al. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy116 · Cited by 76
“00 μg/L) in diabetic patients (13, 16, 25), and 1.”
Hernández-Baixauli, J., Quesada‐Vázquez, S., Mariné-Casadó, R., Cardoso, K. G., Caimari, A., Bas-Prior, J. M. D., Escoté, X., & Baselga‐Escudero, L. (2020) · Nutrients · doi:10.3390/nu12030806 · Cited by 86
“High plasma and/or urine levels of DMA was described to be related to HFD induced IR, fatty liver, and T2D in mice [235].”
Trimethylamine N -oxide: heart of the microbiota–CVD nexus?
Naghipour, S., Cox, A. J., Peart, J. N., Toit, E. F. D., & Headrick, J. P. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000177 · Cited by 86
“betes mellitus)(77); the restriction of TMAO–CVD associations to complex cohorts with multiple risk factors(60,71,75,76,184), and evidence that such associations require one or more extant disorders(8,39); and select cardiovascular effects of inhibition of TMAO production in aged/diseased yet not young and otherwise h…”
BackgroundCholine Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study
Papandreou, C., Bulló, M., Hernández‐Alonso, P., Ruiz‐Canela, M., Li, J., Guasch‐Ferré, M., Toledo, E., Clish, C. B., Corella, D., Estruch, R., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa224 · Cited by 78
“Furthermore, 2 previous studies found that increased plasma betaine concentrations were independently associated with HF risk (11, 12).”
BackgroundResultSchneider, C., Okun, J. G., Schwarz, K. V., Hauke, J., Zorn, M., Nürnberg, C., Ungerer, M. N., Ringleb, P. A., & Mundiyanapurath, S. (2020) · European Journal of Neurology · doi:10.1111/ene.14253 · Cited by 67
“Previous clinical studies demonstrated that elevated TMAO levels are found in patients with diabetes [7] and chronic renal failure [8].”
BackgroundFrom obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 71
Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide
Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 65
Garcia, E., Wolak, J. E., Wang, Z., Li, X. S., Bennett, D. W., Connelly, M. A., Otvos, J. D., Hazen, S. L., & Jeyarajah, E. J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.06.003 · Cited by 66
Metabolites of Gut Microbiota and Possible Implication in Development of Diabetes Mellitus
Guo, Z., Pan, J., Zhu, H., & Chen, Z. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07851 · Cited by 65
DiNicolantonio, J. J., McCarty, M., & OKeefe, J. (2019) · Open Heart · doi:10.1136/openhrt-2018-000890 · Cited by 57
Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis
Ashtary‐Larky, D., Bagheri, R., Ghanavati, M., Asbaghi, O., Tinsley, G. M., Mombaini, D., Kooti, W., Kashkooli, S., & Wong, A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1902938 · Cited by 64
“The findings of an observational study suggested that, in diabetic participants, higher betaine concentrations were associated with all cardiovascular events (Lever et al. 2014).”
Garcia, E., Osté, M. C. J., Bennett, D. W., Jeyarajah, E. J., SHALAUROVA, I. Y., Gruppen, E. G., Hazen, S. L., Otvos, J. D., Bakker, S. J. L., Dullaart, R. P. F., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111813 · Cited by 55
“reported that low betaine levels were associated with CVD events in patients without T2DM, whereas in contrast, elevated betaine levels were associated with CVD in patients with T2DM [27].”
BackgroundKuka, J., Ozola, M., Makrecka‐Kuka, M., Liepiņš, J., Grīnberga, S., Sevostjanovs, E., Vilks, K., Liepinsh, E., & Dambrova, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-71470-4 · Cited by 56
Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
Fretts, A. M., Hazen, S. L., Jensen, P. N., Budoff, M. J., Sitlani, C. M., Wang, M., Otto, M. C. D. O., DiDonato, J. A., Lee, Y., Psaty, B. M., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13242 · Cited by 58
Association between Plasma Trimethylamine N-Oxide Levels and Type 2 Diabetes: A Case Control Study
Kalagi, N. A., Thota, R. N., Stojanovski, E., Alburikan, K. A., & Garg, M. L. (2022) · Nutrients · doi:10.3390/nu14102093 · Cited by 54
Gut microbial metabolism in Alzheimer's disease and related dementias
Kang, J. W., Vemuganti, V., Kuehn, J. F., Ulland, T. K., Rey, F. E., & Bendlin, B. B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00470 · Cited by 60
Steuer, C., Schüetz, P., Bernasconi, L., & Huber, A. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.12.002 · Cited by 53
Ozola, M., Vilšķe̅rsts, R., Korzh, S., Cirule, H., Sevostjanovs, E., Dambrova, M., & Makrecka‐Kuka, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.622741 · Cited by 60
Variability of multi-omics profiles in a population-based child cohort
Gallego-Paüls, M., Hernandéz-Ferrer, C., Bustamante, M., Basagaña, X., Barrera‐Gómez, J., Lau, C. E., Siskos, A., Vives-Usano, M., Ruiz-Arenas, C., Wright, J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02027-z · Cited by 55
Liu, G., Li, J., Li, Y., Hu, Y., Franke, A. A., Liang, L., Hu, F. B., Chan, A. T., Mukamal, K. J., Rimm, E. B., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab053 · Cited by 50
“For example, studies found that higher TMAO concentrations were associated with increased risk of multiple adverse cardiovascular events, such as MI, stroke, or death, among patients undergoing elective coronary angiography, or patients with prevalent kidney disease or chronic systolic heart failure (21, 22, 39, 40).”
BackgroundXia, F., Wen, L., Ge, B., Li, Y., Li, F., & Zhou, B. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1146 · Cited by 60
Vasishta, S., Ganesh, K., Umakanth, S., & Joshi, M. B. (2022) · Metabolomics · doi:10.1007/s11306-022-01905-8 · Cited by 54
“The results demonstrated that TMAO levels were moderately associated with Hispanics when compared with the rest of the ethnic groups.”
BackgroundInfluentialLi, Z., & Suslick, K. S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b00995 · Cited by 45
Ufnal, M., & Nowiński, A. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109271 · Cited by 41
Heaney, L. M., Jones, D. J. L., Mbasu, R. J., Ng, L. L., & Suzuki, T. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9164-6 · Cited by 41
Roy, S. S., yuzefpolskaya, M., Nandakumar, R., Colombo, P. C., & Demmer, R. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227482 · Cited by 40
Metadata
- Authors
- Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., Troughton, R. W., Frampton, C. M., Richards, A. M., & Chambers, S. T.
- Affiliations
- Canterbury Health Laboratories (NZ)
- University of Otago (NZ)
- Corresponding author
- Lever, Michael
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-10
- Volume
- 9
- Issue
- 12
- Pages
- e114969
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4262445
- OpenAlex
- W2045387428
- Cited by
- 223
- References
- 43
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 14 · 2022: 29 · 2021: 25 · 2020: 32 · 2019: 19 · 2018: 12 · 2017: 25 · 2016: 21 · 2015: 13
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Maurice and Phyllis Paykel Trust
- Health Research Council of New Zealand (02/152)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- betaine, trimethylamine N-oxide, dimethylglycine, cardiovascular risk markers, diabetes mellitus, heart failure, myocardial infarction, unstable angina, cardiovascular mortality, acute coronary syndrome, estimated glomerular filtration rate, plasma metabolites, methyl group metabolism, osmolytes, risk stratification, risk prediction model
- MeSH terms
- Aged, Aged, 80 and over, Betaine, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Methylamines, Middle Aged, Risk Factors, Biomarkers, Proportional Hazards Models, Case-Control Studies, Kaplan-Meier Estimate, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.